Government may soon lift export curbs on RAT, RT-PCR kits

NEW DELHI: After Covid vaccines, PPE kits and hand sanitisers, the government may now soon lift export restrictions from RT-PCRrapid antigen test (RAT) and RNA extraction kits etc.

The health ministry has recommended revoking export restrictions imposed on Covid-19 diagnostic kits which were imposed earlier in the wake of large number of infected cases in the country.

In a letter to the directorate general of foreign trade (DGFT), the health ministry has suggested free export of such products. The recommendations are based on deliberations in a meeting of the related Empowered Group-6 in September. The group has decided to revoke the restrictions and allow free export of these products, till further intimation, the letter said. TOI has reviewed a copy of the letter. The final call will be taken by DGFT.

Diagnostic kits, including RT-PCR kits, RNA extraction kits and VTMs were added under restricted category for exports by the DGFT from June 2020, while RAT kits were included in the list in August 2021.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre